Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 673,500 | 530,000 | 584,600 | 446,200 | 395,600 |
| Marketable Securities | 1,930,300 | 1,978,800 | 925,900 | 1,087,100 | 1,034,300 |
| Receivables | 370,000 | 296,500 | 300,700 | 286,300 | 234,900 |
| Inventories | 200,700 | 165,300 | 141,900 | 119,800 | 120,400 |
| TOTAL | $3,237,100 | $3,033,000 | $1,995,700 | $1,969,400 | $1,815,700 |
| Non-Current Assets | |||||
| PPE Net | 461,800 | 384,300 | 346,100 | 321,300 | 301,000 |
| Intangibles | 19,000 | 18,700 | 18,600 | 18,600 | 18,400 |
| Other Non-Current Assets | 115,300 | 85,800 | 87,500 | 85,700 | 50,600 |
| TOTAL | $596,100 | $488,800 | $452,200 | $425,600 | $370,000 |
| Total Assets | $3,833,200 | $3,521,800 | $2,447,900 | $2,395,000 | $2,185,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 397,000 | 315,900 | 267,500 | 256,400 | 232,400 |
| Accrued Expenses | 92,100 | 67,400 | 59,000 | 88,500 | 70,900 |
| TOTAL | $506,400 | $400,100 | $342,800 | $360,200 | $322,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,645,800 | 1,658,800 | 1,072,400 | 1,059,700 | 1,047,100 |
| Deferred Revenues | 1,500 | 1,700 | 1,800 | 1,700 | 4,300 |
| Other Non-Current Liabilities | 181,700 | 109,000 | 98,200 | 92,500 | 51,900 |
| TOTAL | $1,827,500 | $1,767,800 | $1,170,600 | $1,152,200 | $1,099,000 |
| Total Liabilities | $2,333,900 | $2,167,900 | $1,513,400 | $1,512,400 | $1,421,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 384,110 | 382,969 | 369,380 | 366,377 | 366,114 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -557,300 | -629,500 | -675,800 | -695,700 | -788,400 |
| Other shareholders' equity | 2,800 | 3,500 | 3,700 | 2,300 | 1,000 |
| TOTAL | $1,499,300 | $1,353,900 | $934,500 | $882,600 | $764,300 |
| Total Liabilities And Equity | $3,833,200 | $3,521,800 | $2,447,900 | $2,395,000 | $2,185,700 |